根据条款,AnnJi将获得300万美元的预付款,并有权获得未来的开发、监管和商业化里程碑付款,以...查看全文
Avenue Therapeutics(ATXI)04-18 04:15
$Avenue Therapeutics(ATXI)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-048307 Act: 34 Size: 52 KB 网页链接查看全文
Avenue Therapeutics(ATXI)04-18 04:15
$Avenue Therapeutics(ATXI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-048303 Size: 5 KB 网页链接查看全文
Avenue Therapeutics(ATXI)03-30 02:45
$Avenue Therapeutics(ATXI)$ 8-K Current report, item 3.01 Accession Number: 0001437749-24-010044 Act: 34 Size: 155 KB 网页链接查看全文
Avenue Therapeutics(ATXI)03-19 04:25
$Avenue Therapeutics(ATXI)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001437749-24-008294 Act: 34 Size: 7 MB 网页链接查看全文
Avenue Therapeutics(ATXI)03-15 19:25
$Avenue Therapeutics(ATXI)$ 8-K Current report, item 8.01 Accession Number: 0001104659-24-034774 Act: 34 Size: 204 KB 网页链接查看全文
Avenue Therapeutics(ATXI)03-19 05:05
$Avenue Therapeutics(ATXI)$ DEF 14C Other definitive information statements Accession Number: 0001104659-24-035578 Act: 34 Size: 112 KB 网页链接查看全文
Avenue Therapeutics(ATXI)03-19 04:15
$Avenue Therapeutics(ATXI)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-24-035544 Act: 34 Size: 287 KB 网页链接查看全文
格隆汇4月18日丨Avenue Therapeutics盘前涨15.65%,报1.33美元。Avenue Therapeutics周一表示,3月9日与美国FDA就开发用于治疗术后疼痛的静脉注射曲马多(IV Tramadol)举行的官方纪要表明,该机构在拟议研究方案... 网页链接
$Avenue Therapeutics(ATXI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-048303 Size: 5 KB 网页链接
$Avenue Therapeutics(ATXI)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-048307 Act: 34 Size: 52 KB 网页链接
$Avenue Therapeutics(ATXI)$ 8-K Current report, item 3.01 Accession Number: 0001437749-24-010044 Act: 34 Size: 155 KB 网页链接
$Avenue Therapeutics(ATXI)$ DEF 14C Other definitive information statements Accession Number: 0001104659-24-035578 Act: 34 Size: 112 KB 网页链接
$Avenue Therapeutics(ATXI)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001437749-24-008294 Act: 34 Size: 7 MB 网页链接
$Avenue Therapeutics(ATXI)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-24-035544 Act: 34 Size: 287 KB 网页链接
$Avenue Therapeutics(ATXI)$ 8-K Current report, item 8.01 Accession Number: 0001104659-24-034774 Act: 34 Size: 204 KB 网页链接
$Avenue Therapeutics(ATXI)$ PRE 14C Other preliminary information statements Accession Number: 0001104659-24-032410 Act: 34 Size: 112 KB 网页链接
$Avenue Therapeutics(ATXI)$ 8-K Current report, item 5.07 Accession Number: 0001104659-24-032401 Act: 34 Size: 194 KB 网页链接
$Avenue Therapeutics(ATXI)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001104659-24-027037 Act: 34 Size: 207 KB 网页链接